Reply to "risperidone-induced obsessive-compulsive symptoms: Serotonin-dopamine imbalance?" [1]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 5, 2004, Pages 549-

  Alevizos, Basil ^a   Lykouras, Lefteris ^a   Zervas, Iannis M ^a   Christodoulou, George N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; RISPERIDONE; SEROTONIN; SEROTONIN 2 RECEPTOR;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; DEPRESSION; DOPAMINE BLOOD LEVEL; HUMAN; LETTER; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEROTONIN BLOOD LEVEL; SYMPTOMATOLOGY; TARDIVE DYSKINESIA;

EID: 4644275663     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000138770.38729.31     Document Type: Letter

References (5)

1. Duggal HS. Risperidone-induced obsessive-compulsive symptoms: serotonin-dopamine imbalance? J Clin Psychopharmacol. 2003;23:681-682.
2. Alevizos B, Lykouras L, Zervas I, et al. Risperidone-induced obsessive-compulsive symptoms: a series of six cases. J Clin Psychopharmacol. 2002;2:461-467.
3. Sinha BNP, Duggal HS, Nizamie SH. Risperidone-induced obsessive-compulsive symptoms: a reappraisal. Can J Psychiatry. 2000;45:397-398.
4. Ramasubbu R, Ravindran A, Lapierre Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry. 2000;33:236-238.
5. Lykouras L, Alevizos B, Michalopoulou P, et al. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Progr Neuro-Psychopharm Biol Psychiatry. 2003;27:333-346.